- Home
- NCDL vs INMD Comparison
NCDL vs INMD Comparison
Compare NCDL & INMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NCDL
- INMD
- Stock Information
- Founded
- NCDL 2019
- INMD 2008
- Country
- NCDL United States
- INMD Israel
- Employees
- NCDL N/A
- INMD N/A
- Industry
- NCDL
- INMD Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- NCDL
- INMD Health Care
- Exchange
- NCDL NYSE
- INMD Nasdaq
- Market Cap
- NCDL 770.8M
- INMD 887.6M
- IPO Year
- NCDL N/A
- INMD 2019
- Fundamental
- Price
- NCDL $16.01
- INMD $14.36
- Analyst Decision
- NCDL Hold
- INMD Hold
- Analyst Count
- NCDL 3
- INMD 6
- Target Price
- NCDL $15.75
- INMD $17.56
- AVG Volume (30 Days)
- NCDL 221.6K
- INMD 1.0M
- Earning Date
- NCDL 05-08-2025
- INMD 04-28-2025
- Dividend Yield
- NCDL 11.08%
- INMD N/A
- EPS Growth
- NCDL N/A
- INMD 8.69
- EPS
- NCDL N/A
- INMD 2.29
- Revenue
- NCDL N/A
- INMD $392,408,000.00
- Revenue This Year
- NCDL N/A
- INMD $0.40
- Revenue Next Year
- NCDL N/A
- INMD $5.92
- P/E Ratio
- NCDL N/A
- INMD $6.39
- Revenue Growth
- NCDL N/A
- INMD N/A
- 52 Week Low
- NCDL $14.21
- INMD $13.68
- 52 Week High
- NCDL $18.05
- INMD $19.85
- Technical
- Relative Strength Index (RSI)
- NCDL 58.63
- INMD 43.32
- Support Level
- NCDL $15.43
- INMD $14.24
- Resistance Level
- NCDL $16.41
- INMD $14.78
- Average True Range (ATR)
- NCDL 0.24
- INMD 0.37
- MACD
- NCDL 0.09
- INMD 0.07
- Stochastic Oscillator
- NCDL 84.73
- INMD 28.00
About NCDL NUVEEN CHURCHILL DIRECT LENDNG CORP
Nuveen Churchill Direct Lending Corp is a specialty finance company focused predominantly on investing in senior secured loans to private equity-owned U.S. middle market companies. It invest in senior secured loans that typically pay floating interest rates and are senior in the capital structure to junior debt and equity.
About INMD InMode Ltd.
InMode Ltd provides minimally and non-invasive surgical aesthetic and medical treatment solutions in the United States. Its products and solutions address three energy-based treatment categories that include face & body contouring, medical aesthetics, and women's health. InMode has developed products using its technology for plastic surgery, dermatology, gynecology, and ophthalmology. Its product platforms include BodyTite, Optimas, Votiva, Contoura, Triton, EmbraceRF, EvolveX, Evoke, EmpowerRF and Morpheus8. The majority of its revenue comes from the United States.